Cryo-Cell International, Inc. (CCEL) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is neutral — 1 Hold.
The consensus price target is $8.50, representing an upside of 131.6% from the current price $3.67.
Analysts estimate Earnings Per Share (EPS) of $0.38 and revenue of $0.03B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.05 vs est $0.38 (missed -86.8%). 2025: actual $-0.30 vs est $0.11 (missed -372.7%). Analyst accuracy: 0%.
CCEL Stock — 12-Month Price Forecast
$8.50
▲ +131.61% Upside
Average Price Target
Based on 1 Wall Street analysts offering 12-month price targets for Cryo-Cell International, Inc., the price target is $8.50.
The average price target represents a +131.61% change from the last price of $3.67.
CCEL Analyst Ratings
Hold
Based on 1 analysts giving stock ratings to Cryo-Cell International, Inc. in the past 3 months
EPS Estimates — CCEL
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.05
vs Est $0.38
▼ 660.0% off
2025
Actual –$0.30
vs Est $0.11
▼ 136.7% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.
Revenue Estimates — CCEL
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.032B
vs Est $0.032B
▲ 0.1% off
2025
Actual $0.032B
vs Est $0.032B
▲ 0.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
